Low Dose Rapamycin Exacerbates Autoimmune Experimental Uveitis

BACKGROUND: Rapamycin, a potent immune modulator, is used to treat transplant rejection and some autoimmune diseases. Uveitis is a potentially severe inflammatory eye disease, and 2 clinical trials of treating uveitis with rapamycin are under way. Unexpectedly, recent research has demonstrated that...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zili, Wu, Xiumei, Duan, Jie, Hinrichs, David, Wegmann, Keith, Zhang, Gary L., Hall, Mark, Rosenbaum, James T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344911/
https://www.ncbi.nlm.nih.gov/pubmed/22574188
http://dx.doi.org/10.1371/journal.pone.0036589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344911/
https://www.ncbi.nlm.nih.gov/pubmed/22574188
http://dx.doi.org/10.1371/journal.pone.0036589

Ejemplares similares